ADMA Biologics (ADMA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

ADMA Biologics (ADMA) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

ADMA Biologics

· ADMA

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

2.231 B

+0.70%

General

Market Cap: $2.23B
Enterprise Value: $2.39B
Shares Outstanding: 231,770,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 64.71%
Operating Margin: 42.26%
Net Profit Margin: 32.98%
FCF Margin: 22.74%
ROA: 24.69%
ROE: 39.59%
ROIC: 27.55%
Current Ratio: 6.97
Debt-to-Equity: 0.50
Revenue Per Employee: —

Valuation (TTM)

P/E: 13.55
PEG: —
P/S: 4.54
P/FCF: 19.96
P/B: 5.69
EV/EBITDA: 10.19

Growth

Rev 1Y: 19.63%

Income Statement (TTM)

Revenue: $512.28M
Gross Margin: 64.71%
Operating Expenses: $114.91M
Operating Income: $216.5M
Net Profit: $168.96M

Balance Sheet

Rev 1Y Fwd Est

4.93%

Rev 3Y (CAGR)

49.05%

Rev 5Y (CAGR)

64.60%

Rev 10Y (CAGR)

53.17%

EPS 1Y

-25.93%

EPS 1Y Fwd Est

32.78%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $136.02M
Working Capital: $452.45M
Total Assets: $684.21M
Net Debt: $67.82M
Total Liabilities: $276M
Total Equity: $408.21M

Cash Flow Statement (TTM)

Cash Flow from Operations: $136.72M
Cash Flow from Investing: -$14.5M
Cash Flow from Financing: -$76.49M
Free Cash Flow: $116.47M
Capital Expenditures: $20.25M